{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:19:19Z","timestamp":1789510759958,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK106982"],"award-info":[{"award-number":["U01 DK106982"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P50 DK114786"],"award-info":[{"award-number":["P50 DK114786"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK066143"],"award-info":[{"award-number":["U01 DK066143"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK066174"],"award-info":[{"award-number":["U01 DK066174"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U24 DK066116"],"award-info":[{"award-number":["U24 DK066116"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K26 DK138375"],"award-info":[{"award-number":["K26 DK138375"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R21 AT009752"],"award-info":[{"award-number":["R21 AT009752"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R38 HL143613"],"award-info":[{"award-number":["R38 HL143613"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K38 HL169660"],"award-info":[{"award-number":["K38 HL169660"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013137","name":"National Institute of Corrections","doi-asserted-by":"publisher","award":["U24 DK137522"],"award-info":[{"award-number":["U24 DK137522"]}],"id":[{"id":"10.13039\/100013137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00467-024-06580-6","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:52:21Z","timestamp":1737024741000},"page":"1759-1770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigation of a targeted panel of gut microbiome\u2013derived toxins in children with chronic kidney disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Mina","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Mitsnefes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Warady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erum A.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Denburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-3632","authenticated-orcid":false,"given":"Arthur M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"6580_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1053\/j.ajkd.2015.08.025","volume":"67","author":"RL Ruebner","year":"2016","unstructured":"Ruebner RL, Laney N, Kim JY, Hartung EA, Hooper SR, Radcliffe J, Furth SL (2016) Neurocognitive dysfunction in children, adolescents, and young adults with CKD. Am J Kidney Dis 67:567\u2013575","journal-title":"Am J Kidney Dis"},{"key":"6580_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2215\/CJN.02110215","volume":"11","author":"EA Hartung","year":"2016","unstructured":"Hartung EA, Kim JY, Laney N, Hooper SR, Radcliffe J, Port AM, Gur RC, Furth SL (2016) Evaluation of neurocognition in youth with CKD using a novel computerized neurocognitive battery. Clin J Am Soc Nephrol 11:39\u201346","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2215\/CJN.0000000000000318","volume":"19","author":"AM Lee","year":"2024","unstructured":"Lee AM, Xu Y, Hooper SR, Abraham AG, Hu J, Xiao R, Matheson MB, Brunson C, Rhee EP, Coresh J, Vasan RS, Schrauben S, Kimmel PL, Warady BA, Furth SL, Hartung EA, Denburg MR, CKD Biomarkers Consortium (2024) Circulating metabolomic associations with neurocognitive outcomes in pediatric CKD. Clin J Am Soc Nephrol 19:13\u201325","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jpeds.2008.04.026","volume":"153","author":"DJ Weaver Jr","year":"2008","unstructured":"Weaver DJ Jr, Kimball T, Witt SA, Glascock BJ, Khoury PR, Kartal J, Mitsnefes MM (2008) Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J Pediatr 153:565\u2013569","journal-title":"J Pediatr"},{"key":"6580_CR5","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2022030378","volume":"33","author":"J Holle","year":"2022","unstructured":"Holle J, Bartolomaeus H, Lober U, Behrens F, Bartolomaeus T, Anandakumar H, Wimmer M, Vu DL, Kuhring M, Bruning U, Maifeld A, Geisberger S, Kempa S, Schumacher F, Kleuser B, Bufler P, Querfeld U, Kitschke S, Engler D, Kuhrt L, Drechsel O, Eckardt KU, Forslund S, Thurmer A, McParland V, Kirwan J, Wilck N, Mueller D (2022) Inflammation in children with chronic kidney disease linked to gut dysbiosis and metabolite imbalance. J Am Soc Nephrol 33:2259\u20132275","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR6","doi-asserted-by":"publisher","first-page":"F1211","DOI":"10.1152\/ajprenal.00298.2018","volume":"316","author":"GP Hobby","year":"2019","unstructured":"Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM (2019) Chronic kidney disease and the gut microbiome. Am J Physiol Renal Physiol 316:F1211\u2013F1217","journal-title":"Am J Physiol Renal Physiol"},{"key":"6580_CR7","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2215\/CJN.03130312","volume":"7","author":"TM Brady","year":"2012","unstructured":"Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, White CT, Furth S, Warady BA, Mitsnefes M (2012) Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol 7:1930\u20131937","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/HYPERTENSIONAHA.121.17449","volume":"78","author":"MM Mitsnefes","year":"2021","unstructured":"Mitsnefes MM, Xu Y, Ng DK, Hill G, Kimball T, Furth SL, Warady BA (2021) Diastolic function and ambulatory hypertension in children with chronic kidney disease. Hypertension 78:1347\u20131354","journal-title":"Hypertension"},{"key":"6580_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.phrs.2018.03.003","volume":"130","author":"C Cosola","year":"2018","unstructured":"Cosola C, Rocchetti MT, Cupisti A, Gesualdo L (2018) Microbiota metabolites: pivotal players of cardiovascular damage in chronic kidney disease. Pharmacol Res 130:132\u2013142","journal-title":"Pharmacol Res"},{"key":"6580_CR10","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2215\/CJN.12691117","volume":"13","author":"A Jovanovich","year":"2018","unstructured":"Jovanovich A, Isakova T, Stubbs J (2018) Microbiome and cardiovascular disease in CKD. Clin J Am Soc Nephrol 13:1598\u20131604","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, Sartor RB, McIntyre TM, Silverstein RL, Tang WHW, DiDonato JA, Brown JM, Lusis AJ, Hazen SL (2016) Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165:111\u2013124","journal-title":"Cell"},{"key":"6580_CR12","first-page":"1513","volume":"12","author":"T Tourountzis","year":"2022","unstructured":"Tourountzis T, Lioulios G, Fylaktou A, Moysidou E, Papagianni A, Stangou M (2022) Microbiome in chronic kidney disease. Life (Basel) 12:1513","journal-title":"Microbiome Chronic Kidney Disease Life (Basel)"},{"key":"6580_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.2215\/CJN.12161018","volume":"14","author":"NB Shah","year":"2019","unstructured":"Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A (2019) Blood microbiome profile in CKD\u202f: a pilot study. Clin J Am Soc Nephrol 14:692\u2013701","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1113\/EP085283","volume":"101","author":"MR Wing","year":"2016","unstructured":"Wing MR, Patel SS, Ramezani A, Raj DS (2016) Gut microbiome in chronic kidney disease. Exp Physiol 101:471\u2013477","journal-title":"Exp Physiol"},{"key":"6580_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2215\/CJN.0000000000000318","volume":"19","author":"AM Lee","year":"2023","unstructured":"Lee AM, Xu Y, Hooper SR, Abraham AG, Hu J, Xiao R, Matheson MB, Brunson C, Rhee EP, Coresh J, Vasan RS, Schrauben S, Kimmel PL, Warady BA, Furth SL, Hartung EA, Denburg MR, CKD Biomarkers Consortium (2023) Circulating metabolomic associations with neurocognitive outcomes in pediatric CKD. Clin J Am Soc Nephrol 19:13\u201325","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR16","doi-asserted-by":"publisher","first-page":"e005022","DOI":"10.1161\/JAHA.116.005022","volume":"6","author":"SC Hung","year":"2017","unstructured":"Hung SC, Kuo KL, Wu CC, Tarng DC (2017) Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease. J Am Heart Assoc 6:e005022","journal-title":"J Am Heart Assoc"},{"key":"6580_CR17","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1681\/ASN.2015121302","volume":"27","author":"R Poesen","year":"2016","unstructured":"Poesen R, Claes K, Evenepoel P, de Loor H, Augustijns P, Kuypers D, Meijers B (2016) Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD. J Am Soc Nephrol 27:3479\u20133487","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR18","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA, European Uremic Toxin Work Group (2009) Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4:1551\u20131558","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2215\/CJN.00160116","volume":"11","author":"R Poesen","year":"2016","unstructured":"Poesen R, Evenepoel P, de Loor H, Kuypers D, Augustijns P, Meijers B (2016) Metabolism, protein binding, and renal clearance of microbiota-derived p-cresol in patients with CKD. Clin J Am Soc Nephrol 11:1136\u20131144","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR20","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2215\/CJN.07971109","volume":"5","author":"BK Meijers","year":"2010","unstructured":"Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, Kuypers D, Vanrenterghem Y, Evenepoel P (2010) p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 5:1182\u20131189","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR21","doi-asserted-by":"publisher","first-page":"837500","DOI":"10.3389\/fphar.2022.837500","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Xin W, Xiong J, Yao M, Zhang B, Zhao J (2022) The intestinal microbiota and metabolites in the gut-kidney-heart axis of chronic kidney disease. Front Pharmacol 13:837500","journal-title":"Front Pharmacol"},{"key":"6580_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2009.06.019","volume":"54","author":"JF Winchester","year":"2009","unstructured":"Winchester JF, Hostetter TH, Meyer TW (2009) p-Cresol sulfate: further understanding of its cardiovascular disease potential in CKD. Am J Kidney Dis 54:792\u2013794","journal-title":"Am J Kidney Dis"},{"key":"6580_CR23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","volume":"20","author":"T Niwa","year":"2010","unstructured":"Niwa T (2010) Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 20:S2\u2013S6","journal-title":"J Ren Nutr"},{"key":"6580_CR24","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G (2014) The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 25:1897\u20131907","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00726-022-03161-5","volume":"54","author":"N Paeslack","year":"2022","unstructured":"Paeslack N, Mimmler M, Becker S, Gao Z, Khuu MP, Mann A, Malinarich F, Regen T, Reinhardt C (2022) Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease. Amino Acids 54:1339\u20131356","journal-title":"Amino Acids"},{"key":"6580_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/toxins14090645","volume":"14","author":"AM Madella","year":"2022","unstructured":"Madella AM, Van Bergenhenegouwen J, Garssen J, Masereeuw R, Overbeek SA (2022) Microbial-derived tryptophan catabolites, kidney disease and gut inflammation. Toxins (Basel) 14:645","journal-title":"Toxins (Basel)"},{"key":"6580_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","volume":"26","author":"L Dou","year":"2015","unstructured":"Dou L, Sallee M, Cerini C, Poitevin S, Gondouin B, Jourde-Chiche N, Fallague K, Brunet P, Calaf R, Dussol B, Mallet B, Dignat-George F, Burtey S (2015) The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 26:876\u2013887","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","volume":"32","author":"S Al Khodor","year":"2017","unstructured":"Al Khodor S, Shatat IF (2017) Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol 32:921\u2013931","journal-title":"Pediatr Nephrol"},{"key":"6580_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40168-016-0195-9","volume":"4","author":"J Crespo-Salgado","year":"2016","unstructured":"Crespo-Salgado J, Vehaskari VM, Stewart T, Ferris M, Zhang Q, Wang G, Blanchard EE, Taylor CM, Kallash M, Greenbaum LA, Aviles DH (2016) Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Microbiome 4:50","journal-title":"Microbiome"},{"key":"6580_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2215\/CJN.01941205","volume":"1","author":"SL Furth","year":"2006","unstructured":"Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Munoz A, Warady BA (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006\u20131015","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.ajkd.2012.07.018","volume":"60","author":"CJ Wong","year":"2012","unstructured":"Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL (2012) CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60:1002\u20131011","journal-title":"Am J Kidney Dis"},{"key":"6580_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956","journal-title":"Kidney Int"},{"key":"6580_CR33","doi-asserted-by":"publisher","first-page":"e20173035","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on screening and management of high blood pressure in children\u00a0and adolescents (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20173035","journal-title":"Pediatrics"},{"key":"6580_CR34","first-page":"1462","volume":"81","author":"J Janus","year":"2010","unstructured":"Janus J, Moerschel SK (2010) Evaluation of anemia in children. Am Fam Physician 81:1462\u20131471","journal-title":"Am Fam Physician"},{"key":"6580_CR35","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1021\/ac901536h","volume":"81","author":"AM Evans","year":"2009","unstructured":"Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81:6656\u20136667","journal-title":"Anal Chem"},{"key":"6580_CR36","first-page":"132","volume":"4","author":"AM Evans","year":"2014","unstructured":"Evans AM, Bridgewater B, Liu Q et al (2014) High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics 4:132","journal-title":"Metabolomics"},{"key":"6580_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1758-2946-2-9","volume":"2","author":"CD Dehaven","year":"2010","unstructured":"Dehaven CD, Evans AM, Dai H, Lawton KA (2010) Organization of GC\/MS and LC\/MS metabolomics data into chemical libraries. J Cheminform 2:9","journal-title":"J Cheminform"},{"key":"6580_CR38","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/DBP.0000000000000221","volume":"36","author":"SR Hooper","year":"2015","unstructured":"Hooper SR, Laney N, Radcliffe J, Moodalbail D, Hartung EA, Ruebner RL, Jawad AF, Furth SL (2015) Executive functioning in children, adolescents, and young adults with chronic kidney disease. J Dev Behav Pediatr 36:734\u2013742","journal-title":"J Dev Behav Pediatr"},{"key":"6580_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00467-021-05158-w","volume":"37","author":"SR Hooper","year":"2022","unstructured":"Hooper SR, Johnson RJ, Gerson AC, Lande MB, Shinnar S, Harshman LA, Kogon AJ, Matheson M, Bartosh S, Carlson J, Warady BA, Furth SL (2022) Overview of the findings and advances in the neurocognitive and psychosocial functioning of mild to moderate pediatric CKD: perspectives from the Chronic Kidney Disease in Children (CKiD) cohort study. Pediatr Nephrol 37:765\u2013775","journal-title":"Pediatr Nephrol"},{"key":"6580_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.echo.2009.03.003","volume":"22","author":"PR Khoury","year":"2009","unstructured":"Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709\u2013714","journal-title":"J Am Soc Echocardiogr"},{"key":"6580_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2009060609","volume":"21","author":"M Mitsnefes","year":"2010","unstructured":"Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, CKiD Study Group (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137\u2013144","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR42","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23:578\u2013585","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR43","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1523-1755.2004.00525.x","volume":"65","author":"MM Mitsnefes","year":"2004","unstructured":"Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65:1461\u20131466","journal-title":"Kidney Int"},{"key":"6580_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1681\/ASN.2006070691","volume":"18","author":"M Chinali","year":"2007","unstructured":"Chinali M, de Simone G, Matteucci MC, Picca S, Mastrostefano A, Anarat A, Caliskan S, Jeck N, Neuhaus TJ, Peco-Antic A, Peruzzi L, Testa S, Mehls O, Wuhl E, Schaefer F, ESCAPE Trial Group (2007) Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 18:593\u2013598","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR45","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.echo.2006.09.001","volume":"19","author":"WW Lai","year":"2006","unstructured":"Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J, Task Force of the Pediatric Council of the American Society of Echocardiography; Pediatric Council of the American Society of Echocardiography (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413\u20131430","journal-title":"J Am Soc Echocardiogr"},{"key":"6580_CR46","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10741-010-9197-z","volume":"16","author":"S Taddei","year":"2011","unstructured":"Taddei S, Nami R, Bruno RM, Quatrini I, Nuti R (2011) Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev 16:615\u2013620","journal-title":"Heart Fail Rev"},{"key":"6580_CR47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2005030276","volume":"17","author":"MC Matteucci","year":"2006","unstructured":"Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F, ESCAPE Trial Group (2006) Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17:218\u2013226","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR48","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, European Uremic Toxin Work Group (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934\u20131943","journal-title":"Kidney Int"},{"key":"6580_CR49","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.2215\/CJN.02940509","volume":"4","author":"BK Meijers","year":"2009","unstructured":"Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P (2009) p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 4:1932\u20131938","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","volume":"17","author":"YY Chen","year":"2019","unstructured":"Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, Zhao YY (2019) Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med 17:5","journal-title":"J Transl Med"},{"key":"6580_CR51","doi-asserted-by":"publisher","first-page":"e0240446","DOI":"10.1371\/journal.pone.0240446","volume":"15","author":"J Holle","year":"2020","unstructured":"Holle J, Kirchner M, Okun J, Bayazit AK, Obrycki L, Canpolat N, Bulut IK, Azukaitis K, Duzova A, Ranchin B, Shroff R, Candan C, Oh J, Klaus G, Lugani F, Gimpel C, Buscher R, Yilmaz A, Baskin E, Erdogan H, Zaloszyc A, Ozcelik G, Drozdz D, Jankauskiene A, Nobili F, Melk A, Querfeld U, Schaefer F 4C Study Consortium (2020) Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children. PLoS One 15:e0240446","journal-title":"PLoS One"},{"key":"6580_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2215\/CJN.12581019","volume":"15","author":"V Murugapoopathy","year":"2020","unstructured":"Murugapoopathy V, Gupta IR (2020) A primer on congenital anomalies of the kidneys and urinary tracts (CAKUT). Clin J Am Soc Nephrol 15:723\u2013731","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40746-019-00166-3","volume":"5","author":"E Stonebrook","year":"2019","unstructured":"Stonebrook E, Hoff M, Spencer JD (2019) Congenital anomalies of the kidney and urinary tract: a clinical review. Curr Treat Options Pediatr 5:223\u2013235","journal-title":"Curr Treat Options Pediatr"},{"key":"6580_CR54","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1681\/ASN.2019101131","volume":"31","author":"MR Denburg","year":"2020","unstructured":"Denburg MR, Koepsell K, Lee JJ, Gerber J, Bittinger K, Tasian GE (2020) Perturbations of the gut microbiome and metabolome in children with calcium oxalate kidney stone disease. J Am Soc Nephrol 31:1358\u20131369","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1681\/ASN.2021040538","volume":"33","author":"AM Lee","year":"2022","unstructured":"Lee AM, Hu J, Xu Y, Abraham AG, Xiao R, Coresh J, Rebholz C, Chen J, Rhee EP, Feldman HI, Ramachandran VS, Kimmel PL, Warady BA, Furth SL, Denburg MR, CKD Biomarkers Consortium (2022) Using machine learning to identify metabolomic signatures of pediatric chronic kidney disease etiology. J Am Soc Nephrol 33:375\u2013386","journal-title":"J Am Soc Nephrol"},{"key":"6580_CR56","doi-asserted-by":"crossref","unstructured":"RIVUR Trial Investigators; Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA (2014) Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 370:2367-2376","DOI":"10.1056\/NEJMoa1401811"},{"key":"6580_CR57","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.chom.2015.04.006","volume":"17","author":"P Vangay","year":"2015","unstructured":"Vangay P, Ward T, Gerber JS, Knights D (2015) Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17:553\u2013564","journal-title":"Cell Host Microbe"},{"key":"6580_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1870402","volume":"13","author":"L McDonnell","year":"2021","unstructured":"McDonnell L, Gilkes A, Ashworth M, Rowland V, Harries TH, Armstrong D, White P (2021) Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes 13:1\u201318","journal-title":"Gut Microbes"},{"key":"6580_CR59","first-page":"489","volume":"42","author":"H Neuman","year":"2018","unstructured":"Neuman H, Forsythe P, Uzan A, Avni O, Koren O (2018) Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol Rev 42:489\u2013499","journal-title":"FEMS Microbiol Rev"},{"key":"6580_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ntt.2012.09.002","volume":"36","author":"AM Persico","year":"2013","unstructured":"Persico AM, Napolioni V (2013) Urinary p-cresol in autism spectrum disorder. Neurotoxicol Teratol 36:82\u201390","journal-title":"Neurotoxicol Teratol"},{"key":"6580_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/jnc.15604","volume":"161","author":"S Guzman-Salas","year":"2022","unstructured":"Guzman-Salas S, Weber A, Malci A, Lin X, Herrera-Molina R, Cerpa W, Dorador C, Signorelli J, Zamorano P (2022) The metabolite p-cresol impairs dendritic development, synaptogenesis, and synapse function in hippocampal neurons: Implications for autism spectrum disorder. J Neurochem 161:335\u2013349","journal-title":"J Neurochem"},{"key":"6580_CR62","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/1354750X.2010.548010","volume":"16","author":"L Altieri","year":"2011","unstructured":"Altieri L, Neri C, Sacco R, Curatolo P, Benvenuto A, Muratori F, Santocchi E, Bravaccio C, Lenti C, Saccani M, Rigardetto R, Gandione M, Urbani A, Persico AM (2011) Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers 16:252\u2013260","journal-title":"Biomarkers"},{"key":"6580_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2215\/CJN.05210515","volume":"11","author":"TK Mattoo","year":"2016","unstructured":"Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA, Trial Investigators RIVUR (2016) Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) trial. Clin J Am Soc Nephrol 11:54\u201361","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR64","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/JU.0000000000000292","volume":"202","author":"HH Wang","year":"2019","unstructured":"Wang HH, Kurtz M, Logvinenko T, Nelson C (2019) Why does prevention of recurrent urinary tract infection not result in less renal scarring? A deeper dive into the RIVUR trial. J Urol 202:400\u2013405","journal-title":"J Urol"},{"key":"6580_CR65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.urology.2019.11.013","volume":"136","author":"RF Hamdy","year":"2020","unstructured":"Hamdy RF, Pohl HG, Forster CS (2020) Antibiotic prophylaxis prescribing patterns of pediatric urologists for children with vesicoureteral reflux and other congenital anomalies of the kidney and urinary tract. Urology 136:225\u2013230","journal-title":"Urology"},{"key":"6580_CR66","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00431-020-03714-4","volume":"180","author":"M Buettcher","year":"2021","unstructured":"Buettcher M, Trueck J, Niederer-Loher A, Heininger U, Agyeman P, Asner S, Berger C, Bielicki J, Kahlert C, Kottanattu L, Meyer Sauteur PM, Paioni P, Posfay-Barbe K, Relly C, Ritz N, Zimmermann P, Zucol F, Gobet R, Shavit S, Rudin C, Laube G, von Vigier R, Neuhaus TJ (2021) Swiss consensus recommendations on urinary tract infections in children. Eur J Pediatr 180:663\u2013674","journal-title":"Eur J Pediatr"},{"key":"6580_CR67","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1007\/s00431-023-05087-w","volume":"182","author":"CM Parry","year":"2023","unstructured":"Parry CM, Taylor A, Williams R, Lally H, Corbett HJ (2023) Antimicrobial resistance of breakthrough urinary tract infections in young children receiving continual antibiotic prophylaxis. Eur J Pediatr 182:4087\u20134093","journal-title":"Eur J Pediatr"},{"key":"6580_CR68","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2215\/CJN.0000000000000463","volume":"19","author":"AM Lee","year":"2024","unstructured":"Lee AM, Xu Y, Hu J, Xiao R, Hooper SR, Hartung EA, Coresh J, Rhee EP, Vasan RS, Kimmel PL, Warady BA, Furth SL, Denburg MR, CKD Biomarkers Consortium (2024) Longitudinal plasma metabolome patterns and relation to kidney function and proteinuria in pediatric chronic kidney disease. Clin J Am Soc Nephrol 19:837\u2013850","journal-title":"Clin J Am Soc Nephrol"},{"key":"6580_CR69","doi-asserted-by":"publisher","first-page":"990422","DOI":"10.3389\/fcvm.2023.990422","volume":"10","author":"H Kishimoto","year":"2023","unstructured":"Kishimoto H, Nakano T, Torisu K, Tokumoto M, Uchida Y, Yamada S, Taniguchi M, Kitazono T (2023) Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway. Front Cardiovasc Med 10:990422","journal-title":"Front Cardiovasc Med"},{"key":"6580_CR70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/toxins12040229","volume":"12","author":"G Lano","year":"2020","unstructured":"Lano G, Burtey S, Sallee M (2020) Indoxyl sulfate, a uremic endotheliotoxin. Toxins (Basel) 12:229","journal-title":"Toxins (Basel)"},{"key":"6580_CR71","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1053\/ajkd.2003.50104","volume":"41","author":"F Takayama","year":"2003","unstructured":"Takayama F, Taki K, Niwa T (2003) Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 41:S142-145","journal-title":"Am J Kidney Dis"},{"key":"6580_CR72","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s00467-019-04331-6","volume":"34","author":"J Holle","year":"2019","unstructured":"Holle J, Querfeld U, Kirchner M, Anninos A, Okun J, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Duzova A, Anarat A, Shroff R, Bilginer Y, Caliskan S, Candan C, Harambat J, Ozcakar ZB, Soylemezoglu O, Tschumi S, Habbig S, Yilmaz E, Balat A, Zurowska A, Cakar N, Kranz B, Ertan P, Melk A, Azukaitis K, Schaefer F (2019) Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease. Pediatr Nephrol 34:2571\u20132582","journal-title":"Pediatr Nephrol"},{"key":"6580_CR73","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/ndt\/gfg107","volume":"18","author":"G Lesaffer","year":"2003","unstructured":"Lesaffer G, De Smet R, Belpaire FM, Van Vlem B, Van Hulle M, Cornelis R, Lameire N, Vanholder R (2003) Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization. Nephrol Dial Transplant 18:1299\u20131306","journal-title":"Nephrol Dial Transplant"},{"key":"6580_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109795","volume":"116","author":"H Fu","year":"2023","unstructured":"Fu H, Kong B, Zhu J, Huang H, Shuai W (2023) Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4\/AKT\/mTOR signaling pathway. Int Immunopharmacol 116:109795","journal-title":"Int Immunopharmacol"},{"key":"6580_CR75","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","volume":"16","author":"KA Romano","year":"2023","unstructured":"Romano KA, Nemet I, Prasad Saha P, Haghikia A, Li XS, Mohan ML, Lovano B, Castel L, Witkowski M, Buffa JA, Sun Y, Li L, Menge CM, Demuth I, Konig M, Steinhagen-Thiessen E, DiDonato JA, Deb A, Backhed F, Tang WHW, Naga Prasad SV, Landmesser U, Van Wagoner DR, Hazen SL (2023) Gut microbiota-generated phenylacetylglutamine and heart failure. Circ Heart Fail 16:e009972","journal-title":"Circ Heart Fail"},{"key":"6580_CR76","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1097\/HJH.0000000000002569","volume":"38","author":"F Ottosson","year":"2020","unstructured":"Ottosson F, Brunkwall L, Smith E, Orho-Melander M, Nilsson PM, Fernandez C, Melander O (2020) The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease. J Hypertens 38:2427\u20132434","journal-title":"J Hypertens"},{"key":"6580_CR77","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1681\/ASN.2016010039","volume":"27","author":"M Kurella Tamura","year":"2016","unstructured":"Kurella Tamura M, Chertow GM, Depner TA, Nissenson AR, Schiller B, Mehta RL, Liu S, Sirich TL, FHN Study (2016) Metabolic profiling of impaired cognitive function in patients receiving dialysis. J Am Soc Nephrol 27:3780\u20133787","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06580-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:27:25Z","timestamp":1743467245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6580"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06580-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The opinions expressed in this paper do not necessarily reflect those of the National Institute of Diabetes Digestive and Kidney Disease, the National Institutes of Health, the Department of Health and Human Services or the Government of the United\u00a0States of America.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}